Outcomes of non-reduction vs reduction pyeloplasty: a systematic review and meta-analysis.

OBJECTIVE

To compare the surgical outcomes between non-reduction and reduction pyeloplasty in the management of pelvi-ureteric junction obstruction among patients such as postoperative functional outcomes, complication rate, and failure rate through a meta-analysis of comparative studies.

PATIENTS AND METHODS

Electronic databases including PubMed, EMBASE, Scopus, and Cochrane Library, including the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were searched to identify published literature comparing reduction and non-reduction pyeloplasty in adult and paediatric patients. Data on anteroposterior pelvic diameter (APPD), differential renal function (DRF), and complications were extracted. Data synthesis and statistical analysis were done using ReviewManager. Random-effects model and standard mean difference (SMD) were used for calculation of all effect estimates with 95% confidence intervals (CIs) for extrapolation. This study was registered with the International Prospective Register of Systematic Reviews (PROSPERO:CRD42021288645).

RESULTS

Five studies were selected for analysis, encompassing 177 renal units, of which 88 cases were reduction pyeloplasty and 89 cases were non-reduction pyeloplasty. Continuous variables were presented as SMDs with their 95% CIs. Our overall pooled effect estimates showed a statistically significant difference favouring reduction pyeloplasty in terms of postoperative APPD (SMD 1.77, 95% CI 0.43-3.10) and change in APPD (SMD 1.21, 95% CI 0.07-2.36). No statistically significant difference was observed for postoperative DRF (SMD 0.27, 95% CI -0.10 to 0.64) and change in DRF (SMD 0.68, 95% CI -0.39 to 1.74). Subgroup analyses revealed no statistically significant difference for all functional outcomes. Analysis of both groups revealed no significant difference in terms of postoperative complication rate (relative risk [RR] 0.91, 95% CI 0.38-2.16) and failure rate (RR 1.50, 95% CI 0.28-8.04).

CONCLUSION

The evidence suggests that non-reduction pyeloplasty results in comparable postoperative DRF and change in DRF. Although reduction pyeloplasty results in superior APPD and change in APPD compared to non-reduction pyeloplasty, these findings may be clinically negligible. Complication and failure rates between the two groups are comparable.